Aflibercept appears superior to PRP for PDR

Researchers in the United Kingdom compared the 1-year safety and efficacy of intravitreal aflibercept to panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR).
[Read More …]
Source: Daily Dose of Eye Care

Please follow and like us:
RSS
Facebook
Facebook
Google+
Google+
https://www.lvcenter4sight.com/aflibercept-appears-superior-to-prp-for-pdr/

© Copyright Lehigh Valley Center For Sight